Apreo Health Appoints Independent Director and Welcomes Strategic Investor
Apreo Health has appointed David Amerson to its Board of Directors and received a strategic investment from OSF Ventures to advance its BREATHE Airway Scaffold technology for severe emphysema. The company is set to present new clinical data at the ATS 2026 International Conference, highlighting the potential of their innovative treatment approach in improving patient outcomes.
Industry Veteran Dave Amerson Joins Board of Directors; OSF Ventures Joins Investment Syndicate as Company Prepares for Upcoming Presentation at ATS 2026 MENLO PARK, Calif., May 13, 2026 /PRNewswire/ — Apreo Health, a clinical-stage medical device company pioneering a tissue-sparing…